Completed
A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults
NCT04591184
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- National Center for Research and Training on Malaria Ouagadougou, Burkina Faso
- Canadian Centre for Vaccinology, Dalhousie University Halifax, Nova Scotia, Canada
- Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF) Dakar, Senegal
- FARMOVS (PTY) Ltd. Bloemfontein, South Africa